Secukinumab Market Growth Driven by Rising Autoimmune Disease Burden

The Secukinumab market is gaining momentum as the prevalence of chronic autoimmune diseases like plaque psoriasis and psoriatic arthritis continues to climb worldwide. With its proven effectiveness in targeting interleukin-17A (IL-17A), secukinumab i...